The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice
Abstract
Restenosis remains a major cause of morbidity and mortality after coronary angioplasty. Injury-induced inflammation, thrombosis, smooth muscle cell (SMC) proliferation, and neointimal formation contribute to restenosis. These events are linked to circulating glucose-derived advanced gycation endproducts (AGE), known to promote cell proliferation, lipid glycoxidation and oxidant stress. This study evaluates the association between dietary AGE content and neointimal formation after arterial injury in genetically hypercholesterolemic mice. Male, 12-week-old, apolipoprotein E-deficient (apoE(-/-)) mice were randomly assigned to receive either a high AGE diet (HAD; AGE=15000 U/mg), or a similar diet with ten-fold lower AGE (LAD; AGE=1500 U/mg). These mice underwent femoral artery injury 1 week later, and were maintained on their diets for an additional 4 weeks. At 4 weeks after injury, significant decrease in neointimal formation was noted in LAD-fed mice. Neointimal area, intima/media ratio, and stenotic luminal area (LA) were less pronounced in the LAD group than the HAD group (P<0.05). These quantitative differences were associated with a marked reduction ( approximately 56%) of macrophages in the neointimal lesions, as well as an obvious reduction of SMC content of LAD-fed mice. The reduction of neointimal formation in the LAD mice correlated with a approximately 40% decrease in circulating AGE levels (P<0.0005). Immunohistochemistry also showed a reduced ( approximately 1.5-fold) deposition of AGE in the endothelia, SMC, and macrophages in neointimal lesions of LAD-fed mice. These results represent the first evidence in vivo for a causal relationship between dietary AGE and the vessel wall response to acute injury, suggesting a significant potential for dietary AGE restriction in the prevention of restenosis after angioplasty.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another mechanism involves cytokine-induced suppressor of cytokine signalling 1 and 3, which also prevent tyrosine phosphorylation of IRS proteins, by direct interference, or ubiquitylation and subsequent degradation (130,131) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [131]
Citations
Cites
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,512
Self-citationPlump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z. H., Skolnik, E. Y., DELANEY, V. B., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 922
Self-citationSchmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., & Stern, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118175 · Cited by 896
Vlassara, H., Bucala, R., & Striker, L. J. (1994) · PubMed · Cited by 848
Self-citationKoschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Self-citationMouse Models of Atherosclerosis
Breslow, J. L. (1996) · Science · doi:10.1126/science.272.5262.685 · Cited by 549
Nutritional and toxicological aspects of the Maillard browning reaction in foods
O'Brien, J., Morrissey, P. A., & Ames, J. M. (1989) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398909527499 · Cited by 477
Apoptosis: mechanisms and clinical implications
Kam, P. C. A., & Ferch, N. I. (2000) · Anaesthesia · doi:10.1046/j.1365-2044.2000.01554.x · Cited by 463
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 461
Self-citationVlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421
Self-citationEsposito, C., Gerlach, H., Brett, J., Stern, D., & Vlassara, H. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.4.1387 · Cited by 381
Self-citationWard, M. R., Pasterkamp, G., Yeung, A. C., & Borst, C. (2000) · Circulation · doi:10.1161/01.cir.102.10.1186 · Cited by 378
Clinical trials of restenosis after coronary angioplasty.
Popma, J. J., Califf, R. M., & Topol, E. J. (1991) · Circulation · doi:10.1161/01.cir.84.3.1426 · Cited by 331
Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., ARCHER, D. B., & Vlassara, H. (1997) · Europe PMC (PubMed Central) · Cited by 324
Self-citationHemoglobin-AGE: A Circulating Marker of Advanced Glycosylation
Makita, Z., Vlassara, H., Rayfield, E. J., Cartwright, K. J., Friedman, E. A., Rodby, R. A., Cerami, A., & Bucala, R. (1992) · Science · doi:10.1126/science.1411574 · Cited by 251
Self-citationVlassara, H., Fuh, H., Donnelly, T. M., & Cybulsky, M. I. (1995) · Molecular Medicine · doi:10.1007/bf03401582 · Cited by 242
Self-citationAdvanced glycosylation end products in diabetic renal and vascular disease
Bucala, R., & Vlassara, H. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90051-9 · Cited by 213
Self-citationRoqué, M., Fallon, J. T., Badimón, J. J., Zhang, W. X., Taubman, M. B., & Reis, E. D. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.335 · Cited by 208
Self-citationHe, C., Sabol, J., Mitsuhashi, T., & Vlassara, H. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1308 · Cited by 191
Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease
Brownlee, M., Cerami, A., & Vlassara, H. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040503 · Cited by 187
Self-citationBerg, T. J., Bangstad, H. ‐., Torjesen, P. A., Østerby, R., Bucala, R., & Hanssen, K. F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90010-x · Cited by 124
Metabolic transit of early and advanced Maillard products.
Finot, P. A., & Magnenat, E. M. (1981) · PubMed · Cited by 108
Manka, D. R., Collins, R. G., Ley, K. F., Beaudet, A. L., & Sarembock, I. J. (2001) · Circulation · doi:10.1161/01.cir.103.7.1000 · Cited by 104
Mitsuhashi, T., Vlassara, H., Founds, H., & Li, Y. M. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00110-5 · Cited by 90
Self-citationSerum Advanced Glycosylation End Products: A New Class of Uremic Toxins?
Vlassara, H. (2008) · Blood Purification · doi:10.1159/000170145 · Cited by 88
Self-citationHe, C., Zheng, F., Stitt, A. W., Striker, L. J., Hattori, M., & Vlassara, H. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00365.x · Cited by 83
Self-citationSano, H., Nagai, R., Matsumoto, K., & Horiuchi, S. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(99)00011-1 · Cited by 61
Protein glycosylation and the pathogenesis of atherosclerosis
Cerami, A., Vlassara, H., & Brownlee, M. (1985) · Metabolism · doi:10.1016/s0026-0495(85)80008-1 · Cited by 61
Self-citationSgarbieri, V. C., Chichester, C. O., Amaya, J., & Tanaka, M. (1973) · Journal of Nutrition · doi:10.1093/jn/103.5.657 · Cited by 60
Reis, E. D., Roqué, M., Dansky, H. M., Fallon, J. T., Badimón, J. J., Cordon‐Cardo, C., Shiff, S. J., & Fisher, E. A. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210394497 · Cited by 49
Self-citationBoccuzzi, S. J., Weintraub, W. S., Kosinski, A. S., Roehm, J. B., & Klein, J. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00980-6 · Cited by 13
Intervening in Atherogenesis: Lessons from Diabetes
Vlassara, H. (2000) · Hospital Practice · doi:10.3810/hp.2000.11.218 · Cited by 12
Self-citation
Research works printed but not linked: 1
- Lee, 1981, Physiology and safety aspects of Maillard browning of foods, Prog. Food Nutr. Sci., 5, 243
Cited by
Sorted by citations
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Advanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
Self-citationDietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Wang (2012) · doi:10.1161/circresaha.111.261388 · Cited by 957
Advanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751
Metadata
- Authors
- Lin, R.-Y., Reis, E. D., Dore, A. T., Lu, M., Ghodsi, N., Fallon, J. T., Fisher, E. A., & Vlassara, H.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Mount Sinai Hospital (US)
- Corresponding author
- Lin, Reigh-Yi
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 163
- Issue
- 2
- Pages
- 303-311
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2021001924
- Cited by
- 109
- References
- 33
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 2 · 2017: 2 · 2016: 5 · 2015: 8 · 2014: 1 · 2013: 6 · 2012: 3
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG09453, R01AG009453)
- National Heart, Lung, and Blood Institute (R01HL061814, HL61814)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007645, DK07645)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- advanced glycation end products, neointima formation, restenosis, arterial injury, hypercholesterolemia, ApoE-deficient mice, smooth muscle cell proliferation, macrophages, angioplasty complications
- MeSH terms
- Animals, Constriction, Pathologic, Dietary Carbohydrates, Femoral Artery, Hyperlipoproteinemia Type II, Hyperplasia, Male, Mice, Inbred C57BL, Glycation End Products, Advanced, Tunica Intima, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review